USANA Health Sciences Inc
NYSE:USNA
Intrinsic Value
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. [ Read More ]
The intrinsic value of one
USNA
stock under the Base Case scenario is
72.65
USD.
Compared to the current market price of 43.7 USD,
USANA Health Sciences Inc
is
Undervalued by 40%.
USANA Health Sciences Inc's market capitalization is 836m USD.
USNA stock price is 43.7 USD.
USNA stock price (43.7 USD) is 40% less than its Intrinsic Value (72.65 USD).
USNA stock price (43.7 USD) is 27% less than its Relative Value (60.03 USD). Open Relative Valuation
USNA has upside potential of 32% compared to the average analyst price target.
Open Wall St Estimates
USNA has positive Net Income for the last twelve months.
USNA has positive Operating Income for the last twelve months.
USNA's ROE (Return on Equity) for the past 12 months is positive and is equal to 14%.
USNA's Revenue has dropped by 8% over the past 12 months.
USNA's Revenue is forecast to grow at a rate of 8% per year over the next 3 years.
USNA's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 20%.
USNA's Revenue has been falling by 7% per year for the last 3 years.
USNA has positive Free Cash Flow for the last twelve months.
USNA's ROE (Return on Equity) has significantly decreased in the last 3 years from 36% to 14%.
USNA's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 44% to 20%.
USNA has positive three-year average ROE (Return on Equity): 24%. The company is efficient at transforming stockholders' equity into net income.
USNA has very high three-year average ROIC (Return on Invested Capital): 31%. The company is very efficient at using invested capital to generate operating income.
USNA has positive Gross Profit for the last twelve months.
USNA's short-term assets (418m USD) exceed its short-term liabilties (119m USD).
USNA's long-term assets (633m USD) exceed its long-term liabilties (136m USD).
USNA's D/E (Debt to Equity) is very low and is equal to 0.
USNA's Altman Z-Score is very high and is equal to 7.4.
USNA earns more than enough operating income (93m USD) to safely cover interest payments on its debt (68k USD).
Valuation Backtest
USANA Health Sciences Inc
Run backtest to discover the historical profit from buying and selling
USNA
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
USANA Health Sciences Inc
Balance Sheet Decomposition
USANA Health Sciences Inc
| Current Assets | 417.7m |
| Cash & Short-Term Investments | 330.4m |
| Other Current Assets | 87.3m |
| Non-Current Assets | 215m |
| Long-Term Investments | 20m |
| PP&E | 99.8m |
| Intangibles | 47m |
| Other Non-Current Assets | 48.2m |
| Current Liabilities | 118.8m |
| Accounts Payable | 10.1m |
| Other Current Liabilities | 108.8m |
| Non-Current Liabilities | 16.7m |
| Other Non-Current Liabilities | 16.7m |
Earnings Waterfall
USANA Health Sciences Inc
|
Revenue
|
921m
USD
|
|
Cost of Revenue
|
-176.7m
USD
|
|
Gross Profit
|
744.3m
USD
|
|
Operating Expenses
|
-651.2m
USD
|
|
Operating Income
|
93.1m
USD
|
|
Other Expenses
|
-29.3m
USD
|
|
Net Income
|
63.8m
USD
|
Free Cash Flow Analysis
USANA Health Sciences Inc
USNA Profitability Score
Profitability Due Diligence
USANA Health Sciences Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
USANA Health Sciences Inc's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
USNA Solvency Score
Solvency Due Diligence
USANA Health Sciences Inc's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Score
USANA Health Sciences Inc's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
USNA Price Targets Summary
USANA Health Sciences Inc
According to Wall Street analysts, the average 1-year price target for
USNA
is 57.63 USD
with a low forecast of 48.48 USD and a high forecast of 68.25 USD.
Ownership
USNA Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
USNA Price
USANA Health Sciences Inc
| Average Annual Return | -4.66% |
| Standard Deviation of Annual Returns | 32.52% |
| Max Drawdown | -60% |
| Market Capitalization | 836m USD |
| Shares Outstanding | 19 240 500 |
| Percentage of Shares Shorted | 2.2% |
Company Profile
USANA Health Sciences Inc
Country
Industry
Market Cap
Dividend Yield
Description
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,978 full-time employees. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.
Contact
IPO
Employees
Officers
The intrinsic value of one
USNA
stock under the Base Case scenario is
72.65
USD.
Compared to the current market price of 43.7 USD,
USANA Health Sciences Inc
is
Undervalued by 40%.
You don't have any saved screeners yet
